Our mission is to make life better for patients suffering with debilitating diseases – and we believe our medicines will redefine what’s possible. That means raising the bar for treatment expectations in the field of immunology, as we develop and launch medicines that may reduce the burden of diseases such as psoriasis, psoriatic arthritis, rheumatoid arthritis, and gastrointestinal disorders. We embrace the challenge. Together, we'll redefine what's possible.
Setting Your #GOALS
Life with atopic eczema can feel frustrating, but setting goals can help you take control.
#GOALS is an international programme developed and funded by Lilly, created to support people living with atopic eczema who want to be part of a community who are taking control of and setting higher goals for their care. A survey of 2,314 adults living with atopic eczema in 10 countries revealed that people are struggling to cope with their condition and aren’t always getting the support they need. 1
The programme was developed to support people struggling with atopic eczema to have more productive conversations with their healthcare professionals.
1) Eli Lilly & Company, Atopic dermatitis global patient survey results, Data on File 52252, 2019.